You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| THE BARRETT EDGE INC. (46 | 5,097,843 | 0 | 5,097,843 | 0 | 5,097,843 | 9.9% |
| BARRETT EHRLICH | 5,097,843 | 0 | 5,097,843 | 0 | 5,097,843 | 9.9% |
Page 1 of 6 SEC Filing
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G/A
Under the Securities Exchange
Act of 1934
(Amendment No. 1)*
ONCBIOMUNE
PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON
(Title of
Class of Securities)
68235A101
(CUSIP Number)
BARRETT
EHRLICH, 260 MADISON AVE. NEW YORK, NY 10016
(Name, Address
and Telephone Number of Person
Authorized to Receive Notices and Communications)
SEPTEMBER 2, 2015
(Date of Event
which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
☐ Rule
13d-1(b)
☒ Rule
13d-1(c)
☐ Rule
13d-1(d)
* The remainder of this cover
page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Page 2 of 6 SEC Filing
| CUSIP No. 68235A101 | 13G/A | Page 2 of 6 Pages | ||
| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) THE BARRETT EDGE INC. (46-2504958) | |||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐ | |||
| 3. | SEC USE ONLY | |||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION NEW YORK |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 5,097,843 | ||
| 6. | SHARED VOTING POWER -0- | |||
| 7. | SOLE DISPOSITIVE POWER 5,097,843 | |||
| 8. | SHARED DISPOSITIVE POWER -0- |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON *5,097,843 | |||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐ | |||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9% | |||
| 12. | TYPE OF REPORTING PERSON (see instructions) CO | |||
FOOTNOTES
| * | Rebecca Guttman-Ehrlich and reporting person Barrett Ehrlich have equal ownership in The Barrett Edge, Inc. and are the sole owners. |
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Page 3 of 6 SEC Filing
| CUSIP No. 68235A101 | 13G/A | Page
|
| 1. | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) BARRETT EHRLICH | |||
| 2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐ | |||
| 3. | SEC USE ONLY | |||
| 4. | CITIZENSHIP OR PLACE OF ORGANIZATION UNITED STATES |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5. | SOLE VOTING POWER 5,097,843 | ||
| 6. | SHARED VOTING POWER -0- | |||
| 7. | SOLE DISPOSITIVE POWER 5,097,843 | |||
| 8. | SHARED DISPOSITIVE POWER -0- |
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,097,843 | |||
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) ☐ | |||
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 9.9% | |||
| 12. | TYPE OF REPORTING PERSON (see instructions) IN | |||
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Page 4 of 6 SEC Filing
| CUSIP No. 68235A101 | 13G/A | Page 4 of 6 Pages |
Item 1.
| (a) | Name of Issuer ONCBIOMUNE PHARMACEUTICALS, INC. | |
| (b) | Address of Issuer’s Principal Executive Offices 330 Clematis Street, Suite 217, West Palm Beach, Florida 33401 | |
Item 2.
| (a) | Name of Person Filing THE BARRETT EDGE INC. BARRETT EHRLICH | |
| (b) | Address of the Principal Office or, if none, residence 260 MADISON AVE. NEW YORK, NY 10016 | |
| (c) | Citizenship THE BARRETT EDGE INC. IS A NEW YORK CORPORATION BARRETT EHRLICH IS A UNITED STATES CITIZEN | |
| (d) | Title of Class of Securities COMMON | |
| (e) | CUSIP Number 68235A101 | |
Item 3. If this
statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
| (a) | ☐ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). | |
| (b) | ☐ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | ☐ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). | |
| (d) | ☐ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | ☐ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
| (f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | |
| (g) | ☐ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | |
| (h) | ☐ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | ☐ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(J). | |
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Page 5 of 6 SEC Filing
| CUSIP No. 68235A101 | 13G/A | Page 5 of 6 Pages | ||
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
| (a) | Amount beneficially owned: 5,097,843 | |||
| (b) | Percent of class: 9.9% | |||
| (c) | Number of shares as to which the person has: 5,097,843 | |||
| (i) | Sole power to vote or to direct the vote 5,097,843 | |||
| (ii) | Shared power to vote or to direct the vote -0- | |||
| (iii) | Sole power to dispose or to direct the disposition of 5,097,843 | |||
| (iv) | Shared power to dispose or to direct the disposition of -0- | |||
Instruction. For computations regarding securities which represent
a right to acquire an underlying security see §240.13d-3(d)(1).
Item 5. Ownership
of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check
the following ☐.
Item 6. Ownership
of More than Five Percent on Behalf of Another Person.
NOT
APPLICABLE
Item 7. Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
NOT
APPLICABLE
Item 8. Identification
and Classification of Members of the Group.
NOT
APPLICABLE
Item 9. Notice of
Dissolution of Group.
NOT
APPLICABLE
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Follow Theralink Technologies Inc. (OTCMKTS:THER)
Page 6 of 6 SEC Filing
| CUSIP No. 68235A101 | 13G/A | Page 6
|
Item 10. Certification.
| (a) | The following certification shall be included if the statement is filed pursuant to §240.13d-1(b): | |||
| By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. | ||||
| (b) | The following certification shall be included if the statement is filed pursuant to §240.13d-1(c): | |||
| By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. | ||||
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
| MARCH 2, 2016 Date |
| THE BARRETT EDGE INC. |
| /s/ Signature |
| BARRETT Name/Title |
| BARRETT EHRLICH |
| /s/ Signature |
| BARRETT Name/Title |
